Mustgrow obtains $2M CIBC credit line backed by EDC

Mr. Corey Giasson reports MUSTGROW SECURES $2 MILLION LINE OF CREDIT WITH CIBC; GUARANTEED BY EDC Mustgrow Biologics Corp. has secured a $2.0-million line of credit with Canadian Imperial Bank of commerce, guaranteed by Canada's Export Development Canada (EDC) (the LOC). Access to funds will allow Mustgrow to produce its organic mustard-derived biofertility product TerraSante to meet growing demand from United States commercial farming operations. In addition, the LOC will help support working capital requirements for its Canadian sales and distribution division, NexusBioAg. The LOC carries an interest rate linked to Canada's prime rate plus 1.00 per cent per annum. The current Canadian prime rate is 4.95 per cent. EDC has guaranteed the LOC on Mustgrow's behalf. Mustgrow will endeavour to increase the LOC size to support accelerating TerraSante product demand in the U.S. "We are seeing significant uptake from large U.S. commercial farming operations, which further validates the effectiveness, efficiency and economics of our organic biofertility product TerraSante," asserted Corey Giasson, president and chief executive officer of Mustgrow. "Utilizing our LOC on such favourable terms will enable us to build inventory to meet increasing U.S. demand for TerraSante and support NexusBioAg's growing operations here in Canada." About Mustgrow Biologics Corp. Mustgrow Biologics is a fully integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The company's proprietary and third party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, Mustgrow offers a portfolio of third party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants and foliar products. These products are synergistically distributed alongside Mustgrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, Mustgrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize Mustgrow's wholly owned proprietary products and technologies. The company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio of approximately 109 patents that are currently issued and pending, and the sales and distribution of its proprietary and third party product lines through NexusBioAg. Mustgrow is a publicly traded company and has approximately 58.9 million common shares issued and outstanding and 67.5 million shares fully diluted. We seek Safe Harbor.